FDA allows breast implant linked to cancer to remain on US market


WASHINGTON — US health authorities will allow a type of breast implant linked to a rare form of cancer to stay on the market, saying its risks do not warrant a national ban. But the Food and Drug Administration said Thursday it is considering bold warnings for the implants and requiring stricter reporting of problems…

from Living | New York Post https://nyp.st/2Jdq9tl